Search results
Yang Shi is a leading researcher in epigenetics and cancer, who discovered the first histone methyl eraser, LSD1. He studies how histone and RNA modifications regulate gene expression and cancer cell differentiation, and how to target them for therapy.
- Yang Shi — University of Oxford, Medical Sciences Division
Professor of Epigenetics. Before joining Ludwig Oxford in...
- Shi group | Chromatin, RNA modifications and cancer
Professor Yang Shi. Our Lab is interested in chromatin and...
- Yang Shi — University of Oxford, Medical Sciences Division
Yang Shi is a professor of mechanical engineering at the University of Victoria, Canada. His research interests include systems and control, networked and distributed control systems, MPC and distributed MPC, mechatronics, navigation and control of autonomous vehicles, and optimization and control of energy systems.
Yang Shi is a leading researcher in chromatin, RNA modifications and cancer. He joined Ludwig Oxford in 2020 from Harvard Medical School and studies epigenetic regulators in acute myeloid leukaemia and diffuse intrinsic pontine glioma.
Yang Shi Principal Investigator Dr. Yang Shi joined Harvard Medical School as an assistant professor in 1991 and was appointed a Professor of Pathology in 2004.He was Professor of Cell Biology and C.H. Waddington Professor of Pediatrics at Harvard Medical School and the Division of Newborn Medicine at Boston Children’s Hospital prior to joining Ludwig Oxford in 2020.
Yang Shi is a professor of mechanical engineering at the University of Victoria, Canada. He has published papers on networked and distributed systems, model predictive control, CPSs, robotics and mechatronics, and autonomous systems.
May 24, 2024 · Ludwig Oxford Professor Yang Shi has been elected as a Fellow of the Royal Society for his contributions to epigenetics research. The Royal Society, the UK’s distinguished academy of science, has announced the election of 62 new Fellows and Foreign Members, which include Professor Yang Shi.